Effect of cucurbitacins on bilirubin-albumin binding in human plasma. 2007

H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
Biochemistry Department, Holy Spirit University of Kaslik, B.P. 446 Jounieh, Lebanon. helenegreige@usek.edu.lb

The aim of this study is to investigate the effect of three cucurbitacins (Cuc) E, D and I on the bilirubin-albumin binding, both in human serum albumin (HSA) and in plasma. Bilirubin-HSA solution and plasma free of cucurbitacins were prepared as well as others containing serial concentrations of cucurbitacins. The concentration of unbound bilirubin was determined in bilirubin-HSA solution and the direct and total bilirubin concentrations were measured in plasma (with normal or elevated bilirubinemia) by Jendrassik and Grof method. In the conditions we adopted Cuc E and D (to a lesser extent), decreased the levels of unbound bilirubin in bilirubin-HSA solution and decreased direct bilirubin concentration and total bilirubin concentration in plasma in a dose-dependent manner while Cuc I had no effect. The effect of Cuc is related to the presence of native HSA. Thus, when albumin was absent or has been denatured by heating or by urea, Cuc E did not modify bilirubin levels, suggesting that the native structure of albumin is essential for such activity. The interaction of HSA with Cuc E was investigated by fluorescence spectroscopy. Cuc E increased the intrinsic fluorescence of the protein and the magnitude of fluorescence intensity of bilirubin-albumin complex. We concluded that Cuc E and D produced a rearrangement in the structure of albumin, particularly in the domain-II, resulting in an increase in the binding of bilirubin to albumin regardless to whether it's conjugated to glucuronic acid or unconjugated.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006932 Hyperbilirubinemia A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine. Bilirubinemia,Bilirubinemias,Hyperbilirubinemias
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids

Related Publications

H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
March 1999, Journal of the Formosan Medical Association = Taiwan yi zhi,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
December 1987, Pediatrics,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
March 2004, The Journal of pediatrics,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
February 1988, The Journal of pediatrics,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
September 1982, The Journal of pediatrics,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
September 1988, The Journal of pediatrics,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
April 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
February 1985, Pediatrics,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
January 1990, Pharmacology & toxicology,
H Greige-Gerges, and R Abou Khalil, and R Chahine, and C Haddad, and W Harb, and N Ouaini
January 1991, Developmental pharmacology and therapeutics,
Copied contents to your clipboard!